Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 04:01 PM Eastern Daylight Time LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it intends to offer and sell 10,000,000 shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Concert. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
